Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-8184 Paclitaxel in Colorectal Adenocarcinoma
NCT00034190Phase 2Completed
- Sponsor
- Achieve Life Sciences
- Start
- Mar 2002
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in colorectal adenocarcinoma, sponsored by Achieve Life Sciences. Primary endpoint: Objective Response Rate. Started Mar 2002; status: completed.
02
Drugs
paclitaxel
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT00034190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034190.